Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Opportunistic infections news

Show

From To
HIV-Positive Patients at Higher Risk of Late Mortality Following Cryptococcal Infection

New research being presented in a Poster Abstract Session at ID Week 2018, suggests that patients living with HIV have high mortality following cryptococcal infection which persists beyond initial hospitalization. As such, the investigators stress the need to identify patients who are at increased risk of mortality in order to improve patient outcomes.

Published
04 October 2018
From
Contagionlive.com
Uganda: No More Septrin for Aids Patients - Government

People living with HIV/Aids in Uganda (PLWHA) will stop taking Septrin as a complementary drug that fights opportunistic infections such as malaria, diarrhoea and pneumonia, according to the new Health ministry guidelines.

Published
04 September 2018
From
AllAfrica
Price cut on medicine will help preserve the health of more people living with HIV

Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

Published
11 June 2018
From
UNITAID
Raltegravir-Intensified ART: More Rapid Declines in HIV Viral Load But No Impact On IRIS

At the 25th Conference on Retroviruses and Opportunistic Infections (CROI) Diana Gibb, MD, professor of epidemiology, program leader of the Pediatric Program of trials and cohorts at the Medical Research Council Clinical Trials Unit at UCL, London, shared results from a REALITY trial (ISRCTN43622374) which explored the impact of raltegravir intensification of first-line antiretroviral therapy (ART) on immune reconstitution inflammatory syndrome (IRIS).

Published
13 March 2018
From
Contagion Live
Deadly cryptococcal fungi found in public spaces in South Africa

After tuberculosis, cryptococcal meningitis is the leading cause of death in HIV/AIDS patients in Sub-Saharan Africa.

Published
08 December 2017
From
Science Daily
HIV: MSF concerned by high numbers of AIDS deaths in sub-Saharan Africa

Global attention is needed to prevent and treat AIDS in antiretroviral era, with 50 per cent of hospital admissions in MSF hospitals already on treatment and showing signs of clinical failure.

Published
25 July 2017
From
Médecins Sans Frontières (MSF) International
Pneumococcal infections decrease in patients with suppressed HIV

Pneumococcal infections among patients with virologically suppressed HIV decreased significantly in recent years, according to data from a retrospective, case-controlled study.

Published
08 November 2016
From
Healio
WHO confirms antiretroviral therapy reduces the risk of life-threatening HIV-related infections

Adults and children with HIV who start antiretroviral therapy (ART) as early as possible reduce their risk of developing serious HIV-related infections, according to new findings published in the journal Clinical Infectious Diseases on 15 June 2016.

Published
22 June 2016
From
World Health Organization
Cryptococcal meningitis: a blind spot in curbing AIDS

Cryptococcal meningitis, a co-infection of HIV, is a leading killer of patients with AIDS worldwide. Yet it receives little global attention.

Published
15 April 2016
From
The Lancet (requires free registration)
New approach to HIV management in Tanzania and Zambia reduces deaths by almost one-third

A new approach to care for patients with advanced HIV in Tanzania and Zambia combining community support and screening for a type of meningitis has reduced deaths by 28 percent, according to research from the London School of Hygiene & Tropical Medicine.

Published
11 March 2015
From
Eurekalert Medicine & Health
← First12345...7Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.